Marktgröße und Marktanteil von Therapeutika für natürliche Killerzellen bis 2025 – 2031
Natural Killer Cells Therapeutics Market Report Analysis
Natural Killer Cells Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Affimed GmbH
- Celgene Corporation
- Fate Therapeutics
- Fortress Biotech, Inc.
- Glycostem Therapeutics B.V.
- Innate Pharma S.A.
- Nantkwest Inc.
- Nkarta Therapeutics, Inc.
- NKT Therapeutics Inc.,
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Mittlerer Osten und Afrika
Market Segmentation
By Therapeutika
- NK-Zelltherapien
- gegen NK-Zellen gerichtete Antikörper
By Anwendung
- Krebs
- Magen-Darm-Erkrankungen
- immunproliferative Störungen
- andere
By Endbenutzer
- Forschungszentren und -institute
- Krankenhäuser
- andere
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For